Unichem Laboratories Ltd - 506690 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share Certificates under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Unichem Laboratories rises over 7% on USFDA nod for Atenolol tablets
Snapping three-days losing streak, the share price of Unichem Laboratories opened higher, rising 7.4% to touch the day's high of Rs 164 apiece on the BSE Unichem Lab rises 7% after USFDA approval
Shares of the drug firm gained 7.04 per cent to trade at Rs 164 on the BSE. UNICHEM LABORATORIES LTD. - 506690 - ANDA Approval From USFDA For Unichem'S Atenolol Tablets USP
ANDA approval from USFDA for Unichem's Atenolol Tablets USP Unichem Laboratories Ltd - 506690 - ANDA Approval For Unichem''s Buspirone Hydrochloride
ANDA approval for Unichem''s Buspirone Hydrochloride UNICHEM LABORATORIES LTD. - 506690 - Disclosure On Related Party Transactions For The Half Year Ended 30.9.2019
disclosure on related party transactions for the half year ended 30.9.2019 Unichem Labs Q2 net loss narrows to Rs 22.2 crore
Drug firm Unichem Laboratories on Saturday reported a narrowing of its consolidated net loss to Rs 22.20 crore for the quarter ended September 30, Unichem Laboratories Ltd - 506690 - Outcome of Board Meeting
Results for quarter and six months ended 30.9.2019 Unichem Laboratories Ltd - 506690 - Board Meeting Intimation for To Approve Unaudited Financial Results For The Quarter Ended 30.9.2019
UNICHEM LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2019 ,inter alia, to consider and approve Board meeting on 2.11.2019